You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
11 October 2021
Wellbeam Consumer Health – the US company specialising in e-commerce-based wellness brands – has acquired TruSkin for an undisclosed sum.
11 October 2021
Consilient Health has switched its Calci-D chewable tablets from prescription-only to pharmacy (P) status in the UK. Calci-D contains a higher dose of vitamin D3 than existing calcium/vitamin D3 medicines with P status.
8 October 2021
Futura Medical has appointed Jeff Needham – former executive vice president and president of Consumer Self-Care Americas (CSCA) at Perrigo – to its board as a non-executive director.
7 October 2021
Perrigo has announced a change of leadership at its Consumer Self-Care Americas (CSCA) business.
7 October 2021
Australian Pharmaceutical Industries (API) is considering a second takeover proposal from Sigma Healthcare in addition to the offer from Wesfarmers announced in July 2021. Meanwhile, Wesfarmers has acquired a 19.3% stake in API.
7 October 2021
Maxwellia is backing Lovima with a major marketing campaign in the UK, while Bayer Consumer Health has recalled some lots of Lotrimin AF and Tinactin in the US.
6 October 2021
4x4 Capital has acquired a portfolio of sports and active nutrition brands, including Body Fortress and Pure Protein, from private-equity firms KKR and Carlyle for an undisclosed sum.
6 October 2021
Bayer Consumer Health has a new head in Switzerland and two new general managers in North America, while the US Consumer Healthcare Products Association (CHPA) has hired Duffy MacKay.
4 October 2021
Australia has rejected two applications to switch oral contraceptives from prescription to non-prescription status.
4 October 2021
Perrigo has agreed to pay EUR297 million (USD345 million) to settle an Irish tax claim for EUR1.64 billion.